Citation: Hk. Breddin et Vv. Kakkar, Low-molecular-weight heparin in patients with deep-vein thrombosis - Reply, N ENG J MED, 345(4), 2001, pp. 293-293
Authors:
Breddin, HK
Hach-Wunderle, V
Nakov, R
Kakkar, VV
Citation: Hk. Breddin et al., Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis., N ENG J MED, 344(9), 2001, pp. 626-631
Authors:
Skordalakes, E
Dodson, GG
Green, DS
Goodwin, CA
Scully, MF
Hudson, HR
Kakkar, VV
Deadman, JJ
Citation: E. Skordalakes et al., Inhibition of human alpha-thrombin by a phosphonate tripeptide proceeds via a metastable pentacoordinated phosphorus intermediate, J MOL BIOL, 311(3), 2001, pp. 549-555
Authors:
Crawley, J
Lupu, F
Westmuckett, AD
Severs, NJ
Kakkar, VV
Lupu, C
Citation: J. Crawley et al., Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels, ART THROM V, 20(5), 2000, pp. 1362-1373
Authors:
Westmuckett, AD
Lupu, C
Roquefeuil, S
Krausz, T
Kakkar, VV
Lupu, F
Citation: Ad. Westmuckett et al., Fluid flow induces upregulation of synthesis and release of tissue factor pathway inhibitor in vitro, ART THROM V, 20(11), 2000, pp. 2474-2482
Authors:
Green, D
Elgendy, S
Patel, G
Skordalakes, E
Goodwin, CA
Scully, MF
Kakkar, VV
Deadman, JJ
Citation: D. Green et al., Substrate related O,O-dialkyldipeptidyl Psi carboxybenzylphosphonates, a new type of thrombin inhibitor, PHOSPHOR SU, 156, 2000, pp. 151-155
Authors:
Mukherjee, M
Ranlall, N
Patel, G
Rutlin, A
Jehanli, A
Kakkar, VV
Citation: M. Mukherjee et al., Anticoagulant versus amidolytic activity of tissue factor pathway inhibitor in coronary artery disease, BL COAG FIB, 11(3), 2000, pp. 285-291
Authors:
Westmuckett, AD
Lupu, C
Goulding, DA
Das, S
Kakkar, VV
Lupu, F
Citation: Ad. Westmuckett et al., In situ analysis of tissue factor-dependent thrombin generation in human atherosclerotic vessels, THROMB HAEM, 84(5), 2000, pp. 904-911
Authors:
Kakkar, VV
Howes, J
Sharma, V
Kadziola, Z
Citation: Vv. Kakkar et al., A comparative, double-blind, randomised trial of a new second generation LMWH (Bemiparin) and UFH in the prevention of post-operative venous thromboembolism, THROMB HAEM, 83(4), 2000, pp. 523-529
Citation: Vv. Kakkar et F. De Lorenzo, Prognostic role of plasminogen-activator-inhibitor-1 (PAI-1) levels in treatment with streptokinase of patients with acute myocardial infarction - A.Sinkovic: Clin Cardiol 2000;23 : 486-489, CLIN CARD, 23(12), 2000, pp. 877-877
Authors:
De Lorenzo, F
Kadziola, Z
Mukherjee, M
Saba, N
Kakkar, VV
Citation: F. De Lorenzo et al., Haemodynamic responses and changes of haemostatic risk factors in cold-adapted humans, QJM-MON J A, 92(9), 1999, pp. 509-513
Authors:
Patel, G
Husman, W
Jehanli, AM
Deadman, JJ
Green, D
Kakkar, VV
Brennand, DM
Citation: G. Patel et al., A cyclic peptide analogue of the loop III region of platelet-derived growth factor-BB is a synthetic antigen for the native protein, J PEPT RES, 53(1), 1999, pp. 68-74
Authors:
Lupu, C
Poulsen, E
Roquefeuil, S
Westmuckett, AD
Kakkar, VV
Lupu, F
Citation: C. Lupu et al., Cellular effects of heparin on the production and release of tissue factorpathway inhibitor in human endothelial cells in culture, ART THROM V, 19(9), 1999, pp. 2251-2262
Authors:
Carmeliet, P
Ng, YS
Nuyens, D
Theilmeier, G
Brusselmans, K
Cornelissen, I
Ehler, E
Kakkar, VV
Stalmans, I
Mattot, V
Perriard, JC
Dewerchin, M
Flameng, W
Nagy, A
Lupu, F
Moons, L
Collen, D
D'Amore, PA
Shima, DT
Citation: P. Carmeliet et al., Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF(164) and VEGF(188), NAT MED, 5(5), 1999, pp. 495-502
Authors:
Green, D
Skordalakes, E
Scully, MF
Goodwin, C
Merette, S
Burd, A
Kakkar, VV
Deadman, J
Citation: D. Green et al., X-ray crystallographic analyses of human alpha-thrombin complexed to peptidy aminophosphonates: Evidence of a binding mechanism, PHOSPHOR SU, 146, 1999, pp. 545-548
Authors:
Schmitt, JF
Keogh, MC
Dennehy, U
Chen, D
Lupu, F
Weston, K
Taylor, D
Kakkar, VV
Lemoine, NR
Citation: Jf. Schmitt et al., Tissue-selective expression of dominant-negative proteins for the regulation of vascular smooth muscle cell proliferation, GENE THER, 6(6), 1999, pp. 1184-1191
Citation: M. Mukherjee et Vv. Kakkar, Enhancement of lipoprotein lipase activity by tissue factor pathway inhibitor, THROMB HAEM, 82(6), 1999, pp. 1648-1651
Citation: C. Lupu et al., Acute release of tissue factor pathway inhibitor after in vivo thrombin generation in baboons, THROMB HAEM, 82(6), 1999, pp. 1652-1658
Authors:
Mukherjee, M
DeLorenzo, F
Kadziola, Z
Rutlin, A
Ranlall, N
Sembhi, K
Dawson, G
Kakkar, VV
Citation: M. Mukherjee et al., Correlation of circulating 17 beta-oestradiol with haemostatic factors in healthy postmenopausal women, HAEMOSTASIS, 29(6), 1999, pp. 336-342